Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03370861 · ClinicalTrials.gov registry record
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 54
- Enrollment target
NCT03370861 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 54 participants.
The verdict
NCT03370861 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.
Interventions
- BIOLOGICAL Immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03370861
The ClinicalTrials.gov registry entry for NCT03370861 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immunotherapy is the first listed.
NCT03370861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03370861 about?
NCT03370861 is a clinical study titled "How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes". The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.
What is the current status of trial NCT03370861?
This trial is currently terminated. The enrollment target is 54 participants. The study started on 2017-11-08. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03370861?
The interventions under investigation include: Immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT03370861?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.